NASDAQ · Biotechnology

IPSC (IPSC) Stock

$2.02 -1.46% NASDAQ: IPSC Healthcare

Valuation

MetricValue
Price$2.02
Market Cap$174.87M
P/E Ratio-5.04
P/B Ratio1.57
P/S Ratio1.83
EPS (TTM)$-0.53
52-Week High$3.04
52-Week Low$0.43
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-42.67%
ROA-22.28%
ROCE-9.43%
Gross Margin-13.76%
Operating Margin-13.76%
Net Margin-9.17%
Debt/Equity0.17
Current Ratio6.05

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$5.0M$2.0M$7.0M$109.0M
Operating Profit$-95.0M$-134.0M$-147.0M$-138.0M$-15.0M
Net Profit$-96.0M$-131.0M$-137.0M$-127.0M$-10.0M
EPS$-1.74$-2.27$-2.30$-1.61$-0.11
Op Margin—-2574.2%-6556.9%-2096.5%-13.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$437.0M$487.0M$361.0M$353.0M$224.0M
Total Liabilities$41.0M$184.0M$176.0M$192.0M$65.0M
Cash$56.0M$84.0M$47.0M$58.0M$62.0M
Borrowings$25.0M$49.0M$48.0M$54.0M$44.0M

Latest News

Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 GlobeNewswire · Jul 9, 2026 Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight GlobeNewswire · Jun 22, 2026 Here's Why We're Watching Century Therapeutics' (NASDAQ:IPSC) Cash Burn Situation Simply Wall St. · Jun 13, 2026 Century Therapeutics (IPSC) Reports Positive Preclinical Results For Diabetes Cell Therapy CNTY-813 Insider Monkey · Jun 10, 2026 New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026 GlobeNewswire · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-89.0M$14.0M$-88.0M$-110.0M$-104.0M
Investing Cash Flow$-343.0M$-44.0M$47.0M$47.0M$107.0M
Financing Cash Flow$37.0M$0$0$0$0
Net Cash Flow$30.0M$28.0M$-37.0M$12.0M$4.0M
Free Cash Flow$-134.0M$-17.0M$-102.0M$-110.0M$-105.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-5.45
EV / EBITDA-3.14
FCF Yield-48.14%
Quick Ratio10.25
Interest Coverage—
Return 1Y255.00%
Return 3Y-29.35%
Return 5Y-92.23%

Ownership

Insiders Held8.20%
Institutions Held77.92%
Institutions Float Held84.89%
Institutional HolderSharesReport Date
RA Capital Management, L.P.17,754,4302026-03-31
TCG Crossover Management, LLC17,754,4302026-03-31
Versant Venture Management, LLC12,166,1092026-03-31
Deep Track Capital, Lp9,487,7452026-03-31
Commodore Capital Lp8,695,6522026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COEPCoeptis Therapeutics Holdings, Inc. $10.99 -8.57% -4.45 $38.62M 0.00%
CUE $32.57 +1.40% -4.05 $85.59M 0.00%
EQ $2.57 +3.21% -5.28 $91.29M 0.00%
GNTAGenenta Science S.p.A. $1.50 -5.66% -3.98 $28.72M 0.00%
KPTIKaryopharm Therapeutics Inc. $7.60 +2.56% -0.50 $172.24M 0.00%

About IPSC

IPSC is led by CEO Brent Pfeiffenberger, employs 140 people, headquartered in US, publicly traded since 2021.

IPSC stock trades at $2.02 with a market capitalization of $174.87M. The stock is valued at a price-to-earnings (P/E) ratio of -5.04, price-to-book of 1.57, price-to-sales of 1.83. Over the past 52 weeks the stock has ranged between $0.43 and $3.04, and currently trades 33.6% below its 52-week high.

On profitability, IPSC generates a return on equity (ROE) of -42.67%, return on capital employed of -9.43%, an operating margin of -13.76%, a net profit margin of -9.17%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides